Advanced Portable Ventilator Augments Respiratory Care
|
By HospiMedica International staff writers Posted on 04 Oct 2021 |
|
Image: The Ventec V+Pro Ventilator (Photo courtesy of Ventec Life Systems)
A compact ventilator provides continuous or intermittent respiratory support for the care of individuals who require mechanical ventilation.
The V+Pro Ventilator, the result of a collaboration between General Motors (GM; Detroit, MI, USA) and Ventec Life Systems (Ventec; Bothell, WA, USA) in face of the COVID-19 pandemic, is intended to be used for both invasive and non-invasive applications in pediatric through adult patients weighing at least five kg in almost any setting. The first 30,000 units were purchased by the U.S. Department of Health and Human Services (HHS, Washington, DC, USA).
The V+Pro Ventilator is an emergency configuration of the Ventec VOCSN multi-function ventilator, which was originally designed for patients suffering from neuromuscular diseases (such as muscular dystrophies and ALS), impaired lung function (COPD, cystic fibrosis, lung cancers, and emphysema), and other issues. The compact device simultaneously providing ventilation, oxygen, cough assist, hospital grade suction, and nebulization (VOCSN) support. The V+Pro Ventilator adds another (sixth) respiratory treatment, High Flow Therapy (HFT).
Especially useful in patients battling COVID-19, HFT provides caregivers and healthcare professionals an additional tool to meet the COVID-19 patient’s evolving respiratory needs by combining invasive and non-invasive ventilation and HFT from the hospital to home therapy with a single device. The V+Pro Ventilator, which is more than 70% lighter and smaller than current ventilators, features a nine-hour on-board battery, and is controlled through an intuitive touchscreen interface and user-friendly operating system.
“Providing a family of products for patients and their caregivers is an essential element of Ventec Life System's operational objectives, especially when ventilator demand is at the forefront due to the COVID-19 Delta variant,” said Jim Alwan, President and CEO of Ventec Life Systems. “With the addition of our V+Pro ventilator to our product portfolio, providers now have access to alternative respiratory products which they have not had before.”
HFT is a non-invasive form of respiratory support that can lower the intubation rate and mortality in patients with acute hypoxemic respiratory failure (AHRF) by increasing end-expiratory lung volume and reducing regional lung strain, thus improving oxygenation. HFT also decreases respiratory rate and anatomical dead space, thus allowing alveolar ventilation to remain stable. HFT also improves respiratory mechanics, including dynamic compliance, transpulmonary pressure, and ventilation homogeneity.
Related Links:
General Motors
Ventec Life Systems
U.S. Department of Health and Human Services
The V+Pro Ventilator, the result of a collaboration between General Motors (GM; Detroit, MI, USA) and Ventec Life Systems (Ventec; Bothell, WA, USA) in face of the COVID-19 pandemic, is intended to be used for both invasive and non-invasive applications in pediatric through adult patients weighing at least five kg in almost any setting. The first 30,000 units were purchased by the U.S. Department of Health and Human Services (HHS, Washington, DC, USA).
The V+Pro Ventilator is an emergency configuration of the Ventec VOCSN multi-function ventilator, which was originally designed for patients suffering from neuromuscular diseases (such as muscular dystrophies and ALS), impaired lung function (COPD, cystic fibrosis, lung cancers, and emphysema), and other issues. The compact device simultaneously providing ventilation, oxygen, cough assist, hospital grade suction, and nebulization (VOCSN) support. The V+Pro Ventilator adds another (sixth) respiratory treatment, High Flow Therapy (HFT).
Especially useful in patients battling COVID-19, HFT provides caregivers and healthcare professionals an additional tool to meet the COVID-19 patient’s evolving respiratory needs by combining invasive and non-invasive ventilation and HFT from the hospital to home therapy with a single device. The V+Pro Ventilator, which is more than 70% lighter and smaller than current ventilators, features a nine-hour on-board battery, and is controlled through an intuitive touchscreen interface and user-friendly operating system.
“Providing a family of products for patients and their caregivers is an essential element of Ventec Life System's operational objectives, especially when ventilator demand is at the forefront due to the COVID-19 Delta variant,” said Jim Alwan, President and CEO of Ventec Life Systems. “With the addition of our V+Pro ventilator to our product portfolio, providers now have access to alternative respiratory products which they have not had before.”
HFT is a non-invasive form of respiratory support that can lower the intubation rate and mortality in patients with acute hypoxemic respiratory failure (AHRF) by increasing end-expiratory lung volume and reducing regional lung strain, thus improving oxygenation. HFT also decreases respiratory rate and anatomical dead space, thus allowing alveolar ventilation to remain stable. HFT also improves respiratory mechanics, including dynamic compliance, transpulmonary pressure, and ventilation homogeneity.
Related Links:
General Motors
Ventec Life Systems
U.S. Department of Health and Human Services
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Surgical System
Stealth AXiS
New
Immobilization System
Cranial 4Pi Immobilization
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
